Sell Lam Research Stock, Analyst Says. There Are Doubts About Growth.
1. Morgan Stanley downgraded LRCX from Equal-weight to Underweight. 2. Price target reduced from $94 to $92 amid NAND market concerns. 3. Analyst predicts significant slowing in chip-equipment market growth. 4. LRCX shares fell 3.7% despite a 30% rise this year. 5. Concerns over China growth may affect market conditions through 2026.